Costanza Bonnici

Dr. Costanza Bonnici

orcid
Doctoral Researcher

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2025 in Animals
Verified
Journal Article
Open access
PDF file
Costanza BonniciCostanza Bonnici
Costanza Bonnici
MMMaria Federica Marchesi
Maria Federica Marchesi
MFMartina Felici
Martina Felici
FGFederico Ghiselli
Federico Ghiselli
RMRoberta Majer
Roberta Majer
EGEster Grilli
Ester Grilli
L-lysine (L-Lys) is the first-limiting amino acid in swine nutrition, but free-form supplements exhibit poor intestinal absorption, reducing their bioavailability. This study aimed to enhance the gastric retention, controlled intestinal release, and systemic availability of L-Lys by optimizing solid lipid microcapsules (SLMs). SLMs were formulated using hydrogenated triglycerides (C16:0 or C18:1), free fatty acids, and varying emulsifier concentrations. Gastric retention and intestinal release were evaluated in vitro under simulated gastrointestinal conditions (a pepsin buffer at pH 5.0 for 2 h, followed by a pancreatin buffer at pH 6.5 for up to 8 h at 39 °C). SLMs with hydrogenated triglycerides showed significantly higher gastric retention (94–95%) than those with free fatty acids (48%). Specifically, C16:0 triglyceride-based SLMs achieved 74% intestinal release, which was enhanced to 90% with 1% emulsifier. This refined formulation was subsequently evaluated in vivo using weaned pigs (three groups; n = 4) fed a basal cornmeal diet. The treatments included a single oral administration of saline solution (placebo), free L-Lys (0.17 g/kg BW), or L-Lys SLMs (0.38 g/kg BW, equally providing L-Lys at 0.17 g/kg BW). The SLMs delayed the L-Lys plasma peak (T. max. 3–4 h vs. 1 h) and significantly increased the total L-Lys amount in the plasma over 24 h, demonstrating the enhanced relative bioavailability of encapsulated L-Lys.

9 February 2026 in Colloids and Interfaces
Verified
Journal Article
Open access
PDF file
Costanza BonniciCostanza Bonnici
Costanza Bonnici
MMMaria Federica Marchesi
Maria Federica Marchesi
EGEster Grilli
Ester Grilli
Marijana M. DragosavacMarijana M. Dragosavac
Marijana M. Dragosavac
Thyme oil (TO) is emerging as a promising candidate to counteract antimicrobial resistance due to its renowned antimicrobial and anti-inflammatory properties. However, rapid gastric absorption of its bioactive compounds limits its intestinal delivery, where its action is required, so the protection of these components is necessary. This pilot study optimized TO-loaded emulsions for targeted intestinal release. High-shear homogenization and membrane emulsification were compared to formulate single oil in water (O/W) and double water in oil in water (W/O/W) emulsions, screening emulsifiers (lecithin, Tween 20, Tween 80) and functional biopolymers (pectin, sodium alginate). High-shear homogenization with lecithin (0.5%), pectin (1.80%), and sodium alginate (0.2%) yielded stable submicron O/W emulsion (Span = 0.5; d(v,0.5) = 0.21 µm), achieving electrostatic stabilization (ζ-potential = −51.5 ± 1.5 mV) at a target poultry dosage. A pH-responsive behavior was observed: protective hydrogel formed in gastric conditions (d(v,0.5) = 2.64 µm) and maintained stability at intestinal pH (d(v,0.5) = 3.03 µm). Membrane emulsification enabled precise droplet control under mild conditions, producing monodisperse O/W emulsions (d(v,0.5) = 38–59 µm; Span ≤ 1.0) and W/O/W double emulsions (d(v,0.5) = 26.5 µm; Span = 0.6) with ultra-low interfacial tension (0.52 mN·m−1). Repeated membrane passes reduced droplet size to ~6.6 µm. These systems represent a foundational step toward bioactive intestinal delivery, providing a viable antibiotic-free strategy for sustainable livestock production.

7 January 2026 in Aquaculture Nutrition
Verified
Journal Article
Open access
FCFabrizio Caruso
Fabrizio Caruso
ATAndrea Toschi
Andrea Toschi
JGJosé María García-Beltrán
José María García-Beltrán
ACAlberto Cuesta
Alberto Cuesta
Costanza BonniciCostanza Bonnici
Costanza Bonnici
EGEster Grilli
Ester Grilli
For their ability to enhance performance, immune response, and robustness to environmental stressors in both fish and crustaceans, phytogenic compounds are receiving increasing attention from the aquaculture industry as alternatives to traditional feed additives. Numerous studies have investigated the use of a specific combination of organic acids and botanicals (OA + B) in terrestrial animals, but their potential role in aquaculture remains unexplored. The objective of this study is to assess the feasibility of a blend of OA + B (microencapsulated in a lipid matrix; AviPlusAqua – Vetagro S.p.A.) to enhance the health of gilthead seabream. To better assess the potential of the selected blend, both in vitro and in vivo experiments were conducted. Head‐kidney leukocytes (HKLs) were incubated with varying doses of OA + B, then viability and cellular immune parameters were evaluated after 30 min, 2 h, and 4 h. For the in vivo assay, 120 gilthead seabreams (body weight [BW]: 48.00 ± 5.00 g) received a diet supplemented with 0 (control [CTR]), 250, or 500 ppm of OA + B; then growth performance, humoral and cellular immunity, and gene expression of immune‐related genes were evaluated after 15, 30, and 60 days. In vitro, data from gene expression, phagocytosis, and respiratory burst assays demonstrated that OA + B positively stimulate HKLs activity. In vivo results showed increased growth performance (+19% in overall BW; +0.31 specific growth rate [SGR]) from 30 days of supplementation onward, along with improved humoral and cellular immunity. Gene expression analysis of intestinal samples revealed a positive modulation of genes related to intestinal oxidative stress response and a balanced pro‐/anti‐inflammatory cytokine profile at both tested dosages. The results highlight that dietary OA + B supplementation modulates the immune response under homeostatic conditions, as evidenced by modulated expression of immune‐related genes and enhanced phagocytic and respiratory burst activities.